Several app developers are trying to dismantle the accepted tradition of waiting around for healthcare services from doctor appointments to emergency care. ZappRx, launched an app earlier this year to reduce the amount of time consumers wait around for prescription medication at their local pharmacy. Now it’s raised seed funding to develop the app into an effective patient engagement tool and time-saving device to make picking up prescriptions more efficient.
The company founded by Zoe Barry has raised $1 million from a mix of angel and venture investors in a seed round led by Atlas Ventures, an early stage technology and life science investor. It also raised funds from the Life Science Angel Network and other individual angel investors, according to a company statement.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
ZappRx also adding a group of advisers including Jay Silverstein, founding member of Oxford Health, Will Cowen, founder and CEO of healthcare communications network NaviNet, and George Kassabgi, founder of corporate wellness program provider Keas.com.
The app is still in beta and being tested by two doctors at the New York-Presbyterian and Weill Cornell Medical Center and Zitomer Pharmacy.
The idea when the app hits the market is to help patients order and pay for prescriptions electronically. Pharmacists will be able to pre-process insurance information and communicate digitally with the prescriber, according to the statement.
It is also designed to comply with HIPAA and Meaningful Use 2 regulations, according to the company.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
There’s a substantial market opportunity for companies that get the balance right between technology and engagement since about 172 million patients take prescription medication in the U.S.
